Biology Reference
In-Depth Information
Table 1. Some benefits of epoetin alfa therapy
•Increased exercise tolerance
• Improved central nervous system function
• Reduced heart enlargement
•Reduced extreme fatigue
• Increased ability to perform daily functions of life
• Reduced risk of alloimmunization in transplant recipients
• Improved coagulation
References
1 Eschbach JW, Abdulhadi MH, Browne JK, Delano BG, Downing MR, Egrie JC, Evans RW,
Friedman EA, Graber SE, Haley NR et al. (1989) Recombinant human erythropoietin in anemic
patients with end-stage renal disease. Results of a phase III multicenter clinical trial
. Ann Intern
Med
111: 992-1000
2Volgelzang NJ, Brietbart W, Cella D, Curt GA, Groopman JE, Horning SJ, Itri LM, Johnson DH,
Scherr SL, Portenoy RK (1997) Patient, caregiver, and oncologist perceptions of cancer-related
fatigue: Results of tripart assessment survey. The Fatigue Coalition.
Semin Hematol
34: 4-12
3 Demetri GD, Kris M, Wade J, Degos L, Cella D (1998) Quality-of-life benefit in chemotherapy
patients treated with epoetin alfa is independent of disease response of tumor type: Results from
a prospective community oncology study. Procrit Study Group.
J Clin Oncol
16: 3412-3425
4 Glaspy J, Bukowski R, Steinberg D, Taylor C, Tchekmedyian S, Vadhan-Raj S (1997) Impact of
therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during
cancer chemotherapy in community oncology practice. Procrit Study Group.
J Clin Oncol
15:
1218-1234
5 Peeters HR, Jongen-Lavrencic M, Bakker CH, Vreugdenhil G, Breedveld FC, Swaak AJ (1999)
Recombinant human erythropoietin improves health-related quality of life in patients with
rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with dis-
ease activity measures.
Rheumatol Int
18:201-206
6 Gabrilove JL, Cleeland CS, Livingston RB, Sarokhan B, Winer E, Einhorn LH (2001) Clinical
evaluation of once-weekly dosing of epoetin alfa in chemotherapy patients: Improvements in
hemoglobin and quality of life are similar to three-times-weekly dosing.
J Clin Oncol
19:
2875-2882
7 Foote MA, Colowick A, Goodkin DA (2002) Basics of anatomy and physiology: Red blood cells
and anemia.
AMWA J
17: 13-20
8 Watson AJ (1989) Adverse effects of therapy for the correction of anemia in hemodialysis patients.
Sem Nephrol
9: 30-34
9 Bright R (1836) Cases and observations illustrative of renal disease accompanied with the secre-
tion of albuminous urine.
Guy's Hospital Reports
1: 338-379
10 Jourdanet D (1863) De l'anemie des altitudes et de l'anemie en general dans ses rapports avec la
pression del l'atmopshere.
Balliere
(Paris) 44
11 Viault F (1891) Sur l'augmentation considerable du nombre des globules rouges dans le sange
chez les habitants des haut plateaux de l'Amerique du Sud.
CR Acad Press
(Paris) 111: 917-918
12 Viault F (1891) Sur la quantité d'oxygen contenue dans le sang des animaux des hauts pleateaux
de L'Amerique du Sud.
CR Acad Sci
(Paris) 112: 295-298
13 Muntz A (1891) De l'enrichissement du sang en hemoglobine, suivant les conditions d'existence.
CR Acad Sci
(Paris) 112: 298-301
14Meischer F (1893) Ueber die beziehungen zwischen meereshohe und bescharfenheit des blutes.
Korresp-Bl Schweiz Arz
23: 809-830
15 Meischer F (1893) Bemerkungen uber eine verbesserte form der mischipette und ihren einfluss auf
die genauigkeit der blutkorperzahlung.
Korresp-Bl Schweiz Arz
23: 830-832
